Is 35 the new 50? Challenges in determining colonoscopy surveillance recommendations for young patients with incidentally detected adenomas

Cameron, Karla; Moss, Alan

doi:10.1016/j.gie.2018.07.034

Cited by 2 publications

(2 citation statements)

References 9 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, research indicates that screening could be recommended as early as 45 (ACS, 2019). Other published studies indicate that there may be a need to increase the screening age to 35 (Cameron & Moss, 2018). Currently, the ACG (2020) guidelines recommend that those younger than 50 years with a family history of CRC, a family genetic syndrome (familial polyposis), or other risk factors (i.e., being of African American descent or having a diagnosis of inflammatory bowel disease) be screened earlier (Cameron & Moss, 2018).…”

Section: Colonoscopy Screeningmentioning

confidence: 99%

“…Other published studies indicate that there may be a need to increase the screening age to 35 (Cameron & Moss, 2018). Currently, the ACG (2020) guidelines recommend that those younger than 50 years with a family history of CRC, a family genetic syndrome (familial polyposis), or other risk factors (i.e., being of African American descent or having a diagnosis of inflammatory bowel disease) be screened earlier (Cameron & Moss, 2018). Colon polyp and CRC screening can decrease the risk for advanced lesions and decrease mortality rates (Hodges, 2020).…”

Section: Colonoscopy Screeningmentioning

confidence: 99%

See 1 more Smart Citation

Colonoscopy Screening and Polyp Detection in the Southeastern United States

Oden

Nelson

Williams

2022

Gastroenterology Nursing

View full text Add to dashboard Cite

Cancer is the second leading cause of death in the United States (U.S.) (Centers for Disease Control and Prevention, 2017). according to Siegel, Miller, and jemal (2019), it is estimated that over 1.7 million people will be diagnosed with cancer and, of those diagnosed, over 600,000 will die from the disease. The National Cancer Institute (2019) estimates that between 3% and 35% of cancer-related deaths could be prevented by screening. Screening may also decrease morbidity rates, as it is often easier to treat an early-stage cancer as opposed to a late-stage cancer. BackgroundColorectal cancer (CRC) is the third cause of cancerrelated deaths (excluding certain skin cancers), and is the third most common cancer in both men and women (Centers for Disease Control and Prevention, 2020). There are an estimated 240,000 new cases diagnosed each year with approximately 112,000 deaths. arnold et al. ( 2017) estimate that the incidence rate for CRC will increase by 60% by the year 2030.advances in screening and treatment of CRC in the U.S. have resulted in decreased mortality rates (Hunleth, Steinmetz, McQueen, & james, 2016). Screening for CRC allows for detection and removal of precancerous polyps, which are directly linked to a decline in incidence rates (Lieberman et al., 2016). furthermore, according to the american Cancer Society (aCS, 2020), screening and early detection leads to an increase in survivability among CRC

show abstract

Section: Colonoscopy Screeningmentioning

confidence: 99%